ASSEMBLY BIOSCIENCES INC (ASMB) Stock Balance Sheet
NASDAQ:ASMB - Nasdaq - US0453962070 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 28.45M | 19.84M | 52.42M | 45.63M | 59.44M | |||
| Marketable Securities | 66.50M | 110.41M | 39.19M | 101.00M | 156.97M | |||
| Receivables | 0.00 | 43.00K | 944.00K | 336.00K | 1.23M | |||
| Other Current Assets | 3.26M | 3.50M | 4.41M | 7.24M | 6.85M | |||
| Total Current Assets | 98.21M | 133.79M | 96.97M | 154.20M | 224.49M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.74M | 2.72M | 3.94M | 7.18M | 10.73M | |||
| Investments And Advances | N/A | N/A | 0.00 | 27.97M | N/A | |||
| Goodwill | N/A | N/A | N/A | 0.00 | 12.64M | |||
| Intangibles | N/A | N/A | N/A | 0.00 | 29.00M | |||
| Other Non-Current Assets | 312.00K | 312.00K | 889.00K | 1.70M | 6.39M | |||
| Total Non-Current Assets | 2.05M | 3.04M | 4.83M | 36.86M | 58.76M | |||
| TOTAL ASSETS | 100.26M | 136.82M | 101.79M | 191.06M | 283.25M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.68M | 7.85M | 13.80M | 13.41M | 19.84M | |||
| Accounts Payable | 1.33M | 461.00K | 2.49M | 2.66M | 4.60M | |||
| Other Current Liabilities | 32.62M | 30.91M | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 41.63M | 39.23M | 16.30M | 16.07M | 24.43M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | 2.53M | |||
| Other Non-Current Liabilities | 32.62M | 56.50M | 2.83M | 6.06M | 15.71M | |||
| Total Non-Current Liabilities | 32.62M | 56.50M | 2.83M | 6.06M | 18.24M | |||
| TOTAL LIABILITIES | 74.26M | 95.73M | 19.13M | 22.13M | 42.68M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -815.59M | -785.75M | -724.52M | -631.43M | -501.57M | |||
| Additional Paid In Capital | 841.74M | 826.92M | 807.94M | 800.73M | 742.39M | |||
| Common Shares | 6.00K | 5.00K | 49.00K | 48.00K | 34.00K | |||
| Shares Outstanding | 6.35M | 5.48M | 4.07M | 4.01M | 2.83M | |||
| Tangible Book Value per Share | 4.09 | 7.50 | 20.29 | 42.13 | 70.17 | |||
| Total Shareholders' Equity | 26.00M | 41.10M | 82.66M | 168.93M | 240.58M | |||
| TOTAL LIABILITIES AND EQUITY | 100.26M | 136.82M | 101.79M | 191.06M | 283.25M | |||
| Statistics | ||||||||
| Current Ratio | 2.36 | 3.41 | 5.95 | 9.59 | 9.19 | |||
| Return On Assets (ROA) | -40.70% | -44.75% | -91.45% | -67.97% | -21.94% | |||
| Return On Equity (ROE) | -156.92% | -148.98% | -112.61% | -76.87% | -25.83% | |||
All data in USD , ROIC based on taxRate of 0.21